Topics
Sector
Geography
Subject

Videos Library

Event Videos

1938
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

Please find the latest videos from entire, recent Evidence Life Science events.

Real-World External Data USA Leveraging registries & novel external data sources, AI & big data, to achieve groundbreaking real world insights

Online Conference - one half day (8am LA, 11am NYC) - 23 May, 2023

MedAffairs Omnichannel Achieving engagement & insights, whilst delivering intelligent & personalised stakeholder value

Online Conference - one half day (8am NYC, 2pm Paris) - 13 April, 2023
Presentation

Unlocking Possibilities: A Journey to Cross-functional Omnichannel Readiness

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
Speakers

Claudia Pereira

Senior Medical Writer
OPEN Health

Bill McNish

Senior Omnichannel Strategist
OPEN Health 

Robyn Davies

Account Director
OPEN Health 

HYBRID REAL-WORLD EVIDENCE Leveraging Internal & External Data, incorporating Technologies, for Advanced Analytics & Insights

Online Conference - one half day (9am NYC, 2pm Paris) - 15 March, 2023
Presentation

Transform your RWE to effectively inform decision making

Related topics: Real-World Evidence & Late-Phase Research
Availability: FREE
  • Using RWE to assess recent plans and guidelines
  • Assessing the feasibility and value within various RWE sources and translating into actionable insights
  • Provide wider stakeholder groups with key evidence to support future planning and service design
  • Case studies demonstrating RWE led healthcare improvements
Speaker

Chris Rolfe

UK RWE Data and Product Manager 
Open Health 

MedAffairs Insights Delivering value to stakeholders & facilitating excellence, with a smarter medical affairs organisation

Online Conference - one half day (9am NYC, 2pm Paris) - 14 March, 2023

MedAffairs Capabilities & Effectiveness Developing the next generation medical affairs function to add-value to external & internal stakeholders

Online Conference - 2 half days (8am NYC, 2pm Paris) - November 15-16, 2022
Presentation

Optimising Medical Affairs Effectiveness

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
  • What makes an effective medical affairs department?
  • What are the trends for the future of medical affairs?
  • What tools and approaches should be used to enable Medical Affairs?
Speaker

Samin Saeed

Chief Medical Officer
PharmaReview

Presentation

Within3 Showcase

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology, Capabilities & Effectiveness
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

MedAffairs Omnichannel USA Achieving engagement & insights, whilst delivering intelligent & personalized stakeholder value

Online Conference - one half day (8am Pacific, 10am Central, 11am Eastern) - January 31st, 2023
Presentation

Translating Insights into Content for Omnichannel success

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Effectively 
  • Efficiently
  • Responsibly
Speaker

Tessa Pugh

CEO
PharmaReview

Presentation

Insights into HCP digital content consumption preferences –what, when, why, and where?

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • What drives HCP to consume independent education?
  • Lessons learnt in reaching target HCP audiences - and how to keep then engaged
  • Insights into HCP browsing habits – platforms, times, engagement limits
Speakers

Caroline Halford

Development Director for Medical Education
Springer Healthcare

David Braca

Regional Sales Director - US
Springer Healthcare

MedAffairs Omnichannel Achieving engagement & insights, whilst delivering intelligent & personalised stakeholder value

Online Conference - 2 half days (8am NYC, 2pm Paris) - October 18-19, 2022
Presentation

From Theory into Practice: Making Omnichannel Actionable in Medical Affairs

Related topics: Digital & Technology
Availability: FREE
Speakers

Gemma Allen

Expert in Technology Innovation
Open Health

Oliver Childs

Expert in Creative Scientific Communications
Open Health

Presentation

Reaching and engaging HCPs with congress-based education: Lessons learnt on the journey towards omnichannel

Related topics: Digital & Technology
Availability: FREE
  • What drives HCPs to access independent congress-based education?
  • Insights into HCP content consumption – when, where, and what they like to view
  • The challenges in learning curves based on 3 years of content delivery
Speakers

Chris Bassett

Sales Director 
Springer Healthcare

Simon Fry

Digital Product Development Director
Springer Healthcare

MedAffairs in Emerging Markets Leveraging Limited Resources whilst Enhancing Capabilities & Effectiveness to Deliver Value

Online Conference - 2 half days (9am Paris, 3pm Singapore) - September 13-14, 2022

Real-World Data Analytics & Technologies Leveraging AI, big data, registries & cutting-edge data sources, to harness RWE actionable insights

Online Conference - 2 half days (8am NYC, 2pm Paris) - September 27-28, 2022
Presentation

Deep RWE - a case study

Related topics: Real-World Evidence & Late-Phase Research, Digital & Technology
Availability: FREE
Speaker

Joaquin Casariego

Senior Advisor 
Savana 

Presentation

Earlier diagnosis of complex rare disease patients utilizing machine learning

Related topics: Real-World Evidence & Late-Phase Research, Digital & Technology
Availability: FREE
Speaker

Chris Rolfe

Consultant, Real-World Evidence
Open Health 

MedAffairs Content & Publication Strategy Fresh approaches to producing engaging, value-adding, personalised content in a hybrid, omnichannel world

Online Conference - 2 half days (8am NYC, 2pm Paris) - June 14-15, 2022

MedAffairs Insight Generation & Management Processes & technologies to enable a smarter organisation, that delivers personalised value

Online Conference - 2 half days (8am NYC, 2pm Paris) - April 26-27, 2022
Presentation

Translating insights into content

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Effectively 
  • Efficiently
  • Responsibly 
Speaker

Tessa Pugh

CEO
PharmaReview

Hybrid Medical Communications Leveraging classical & digital channels & content, to engage & deliver stakeholder value

Online Conference - 2 half days (9am NYC, 2pm Paris) - March 15-16, 2022

Next Generation Real-World Registries Leveraging patient, disease or product registries, AI & big data, to achieve ground-breaking real-world insights

Online Conference - 2 half days (8am NYC, 2pm Paris) - February 22-23, 2022
Presentation

Deep RWE: The most realistic clinical data possible

Related topics: Real-World Evidence & Late-Phase Research
Availability: FREE
  • Retrieving the actual complete information of what is happening at each point of care
  • Having access to the complete medical records information: Every single patient, every single variable, the most realistic data source possible
  • In order to get this, you need a system which is able to retrieve information:
    • From any healthcare provider (as long as they have electronic health records -EHR-, paper doesn't work)
    • Natural Language Processing: 80% of the variables and outcomes are going to be in the clinical narratives´ free text
Speaker

Ignacio Medrano

Founder & Chief Medical Officer 
Savana 

KOL Engagement & Insights External expert communications & collaborations to facilitate insights & evidence

Online Conference - 2 half days (8am NYC, 2pm Paris) - November 16-17, 2021
Presentation

KOL insights in a digital world

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices.  Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.

Speaker

Christina Hoffman

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

Presentation

Community engagement from a medical publisher`s point of view

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

Let's take the idea of KOL engagement a bit further! Discover how to bridge the knowledge gap in multiple communities by sharing scientific information with relevant stakeholders simultaneously thus leveraging existing networks, relationships, and channels to foster connections. Join us in exploring the ideas and hear a few practical real-life cases of community engagement.

Speakers

Iola Forster

Strategic Competence Lead, Industry & Society Services
Karger Publishers

Geoff Covey

General Manager, Karger UK
Karger Publishers

MedAffairs OmniChannel Achieving engagement & insights, whilst delivering intelligent & personalised stakeholder value

Online Conference - 2 half days (8am NYC, 2pm Paris) - February 1-2, 2022
Presentation

Maximising the omnichannel ecosystem for medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Ensuring accurate KOL ID for engagement
  • Utilising engagement channels for optimal outcomes
  • Connecting data to verify understanding & strategy
Speaker

Nina Levin

Vice President - Client Success
Within3

Presentation

Paving the way: The reality of implementing omnichannel in medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speakers

James Turnbull

Global Head of Omnichannel Communications
OPEN Health

Jenny Ghith

Senior Director, Omnichannel Strategy and Innovation Lead, Global Scientific Communications 
Pfizer Oncology

MedAffairs Digital Virtual stakeholder engagement & insights through technologies, processes & capabilities

Online Conference - 2 half days (8am NYC, 2pm Paris) - October 5-6, 2021
Presentation

Digital capabilities: Closing the medical affairs "Insight Gap"

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

How to thrive in this new “hybrid” world

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Rosie Humphreys

Digital Communications Director 
Open Health 

Real World Smart Data Leveraging AI, big data, EHR, cloud & novel RWE technologies for advanced analytics & insights

Online Conference - 2 half days (8am NYC, 2pm Paris) - October 26-27, 2021
Presentation

Raising the bar on RWE: AI, Big Data, NLP and a methodology that sets the gold standard

Related topics: Real-World Evidence & Late-Phase Research, Digital & Technology
Availability: FREE

Traditional methods of evidence generation from electronic health records are no longer fit for purpose.  Discover how AI techniques such as clinical natural language processing (cNLP) can generate deep RWE to deliver clinical and economic value for industry. Hear about:

·  The limitations of traditional methods of evidence generation from electronic health records

·  The benefits of AI-based techniques such as cNLP

·  A gold standard for high-quality RWE for deeper insights at scale and speed

·  Ideas for applying deep RWE across the Pharma R&D and commercial lifecycle

Speaker

Ignacio Medrano

Founder & Chief Medical Officer 
Savana 

MedAffairs Capabilities & Effectiveness Developing the next generation medical affairs function to add-value to external & internal stakeholders

Online Conference - 2 half days (8am NYC, 2pm Paris) - July 20-21, 2021
Presentation

Positively challenging: A new mindset for HCP engagement in Medical Affairs

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
  • How can medical affairs navigate the challenges of rapidly changing internal and external landscapes?
  • What value can medical affairs deliver with a new mindset?
  • How can we empower teams to drive impactful engagement with the healthcare community?
Speakers

Jessica Ingram

Senior Vice President, Learning & Development
OPEN Health Medical Communications

Sophie Officer-Thorley

Senior Account Manager - Learning and Development
OPEN Health Medical Communications

Presentation

Market assessment to fuel actionable insights for medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE

The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices.  Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.

Speaker

Christina Hoffman

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

KOL ENGAGEMENT External expert communications & collaborations to facilitate insights & evidence

Online Conference - 2 half days (8am NYC, 2pm Paris) - May 18-19, 2021
Presentation

Informing oncology strategies through insights and engagement

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE

Innovation in an already crowded oncology space has created a challenge for medical affairs.  The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the  scientific need of experts, while continuously demonstrating value.  To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to  leverage this information to inform targeted decisions and investments. 

Speaker

Robert Groebel

Vice President - Global Medical Strategy
Monocl

Next Generation Real-World Registries Leveraging patient, disease or product registries, AI & big data, to achieve ground-breaking real-world insights

Online Conference - 2 half days (8am NYC, 2pm Paris) - April 20-21, 2021
Presentation

AI-driven literature discovery provides critical context for interpreting registry information

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speakers

Jeffrey Saffer

CEO and Co-founder 
Quertle

Chahrazed Poignant

Business Development Manager
Karger

Gregor Bangert

Regional Manager
Karger

Presentation

Using RWD and machine Learning to drive patient identification in rare diseases

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Orphan Drugs, Digital & Technology
Availability: FREE
  • UK Data Sources and Access:
    • Hospital Episode Statistics
    • Primary care datasets – GPES, CPRD, OPCRD
  • Overview of key processes
  • Expanding the global reach
  • What the future could hold?
Speaker

Tony Cox

Development Director Real-World Evidence
OPEN Health

MedTech & Diagnostics Value & Access Developing global evidence & capabilities to demonstrate value and achieve market access in key local markets

Online Conference - 2 half days (8am NYC, 2pm Paris) - March 30-31, 2021
Presentation

How value-based approach is transforming the MedTech industry

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Integrating market access, medical affairs and deep clinical understanding
  • Building a strategy with KOL engagement and collaboration with scientific societies - a case study explaining the process and decision-making algorithms
  • Clinical guidelines, the reimbursement system and medical standards and protocols as a key focus of the strategy
Speaker

Julya Zuenkova

Business Development Director
Xstrahl Group

Presentation

From value-based healthcare to network value

Related topics: MedTech, Market Access & HEOR
Availability: FREE

COVID-19 significantly impacted how providers reach out to patients. Besides, there has been a series of changes in the reimbursement and funding of medical technologies and procedures. These aspects created opportunities to address new market needs and leverage data and learning to deliver more value to a growing network of payers, providers, and patients. Welcome to the new era of Network Value.

Speaker

Ernesto M. Nogueira

CEO and Founder
ValueConnected

MedAffairs Digital Virtual stakeholder engagement & insights through technologies, processes & capabilities

Online Conference - 2 half days (8am NYC, 2pm Paris) - March 9-10, 2021
Presentation

Omnichannel in Medical Affairs - an evidence-based approach to personalising healthcare communications

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • So what does omnichannel actually mean for Medical Affairs?
  • Examples of evidence and data-based healthcare communications
  • Right message, right place, right audience
Speaker

James Turnbull

Senior Vice President, Omnichannel & Digital
OPEN Health

Presentation

Beyond Knowledge Transfer: Generating Actionable Insights for Medical Affairs

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speakers

Christina Hoffman

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

Alessandro Pontes-Arruda

Vice-President, U.S. Medical Head Cardiovascular and Established Products
Sanofi

Gokhan Tanju

Executive Director, Business Intelligence
Medscape Medical Affairs

MedAffairs for MedTech & Diagnostics Developing & leveraging medical affairs capabilities to offer added-value to stakeholders in medical devices

Online Conference - 2 half days (8am NYC, 2pm Paris) - February 9-10, 2021
Presentation

Stakeholder mapping & engagement in established and emerging markets

Related topics: MedTech, Diagnostics, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speaker

Eric Noehrenberg

President
NIPC

Presentation

MedTech KOL Engagement During COVID: Real-world case studies

Related topics: MedTech, Diagnostics, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

MedAffairs Oncology Enhancing communications, evidence & insights to add-value to stakeholders in the cancer health ecosystem

Online Conference - 2 half days (8am NYC, 2pm Paris) - January 26-27, 2021
Presentation

Informing oncology strategies through insights and engagement

Related topics: Medical Affairs & Stakeholder Engagement, Oncology
Availability: FREE

Innovation in an already crowded oncology space has created a challenge for medical affairs.  The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the  scientific need of experts, while continuously demonstrating value.  To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to  leverage this information to inform targeted decisions and investments. 

Speaker

Robert Groebel

Vice President - Global Medical Strategy
Monocl

Presentation

Oncology-Specific KOL Engagement During COVID: Real-world case studies

Related topics: Medical Affairs & Stakeholder Engagement, Oncology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

MedAffairs Digital Virtual stakeholder engagement & insights through technologies, processes & capabilities

Online Conference - 2 half days (8am NYC, 2pm Paris) - October 20-21, 2020
Presentation

How to maintain valuable peer-to-peer dialogue in a virtual setting? Insights and learnings from 2020

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Insights and feedback from HCPs on 2020 virtual activities
  • Recommendations for impactful virtual engagements in 2021
  • How to effectively have peer-to-peer conversations virtually
Speaker

Gemma Allen

Head of Digital Communications
Open Health

Presentation

Digital transformation for medical affairs in practice

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

KOL ENGAGEMENT External Expert communications & collaborations to facilitate insights & evidence

2 days x 3 hours (9am NYC, 3pm Paris) - July 28-29, 2020
Presentation

KOL Engagement from a Medical Publisher’s viewpoint

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • How KOL-expertise can be accessed to curate and publish high quality content for a variety of target audiences
  • Possibilities of engaging different types of KOLs to fill knowledge gaps via medical communications.
  • Values and benefits of co-operating with medical publishing professionals when involving and/or addressing KOLs.
Speakers

Joachim Flickinger

Head of Clinical & Patient Markets
Karger Publishers, Switzerland

Iola Gulijew

Strategic Competence Lead, Industry & Society Services
Karger Publishers, Switzerland

Presentation

Within3 product showcase

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

Within3 offers a virtual engagement platform that gives stakeholders the freedom to communicate anytime, anywhere, on any device

Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

MedAffairs Leaders Forum

London, UK - March 3-5, 2020
Presentation

Building best-in-class MSL functions for the 21st century healthcare industry

Related topics: Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
Speaker

Helen Kane

Founder & Managing Director
ONE MSL, UK

Presentation

Considerations for evidence generation early in the product development process

Related topics: Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Clinical
Availability: FREE
Speaker

Sergio Diaz

Patient-Centred Outcomes Consultant
OPEN VIE

R&D Data Intel Leaders Forum

Basel, Switzerland - January 27-28, 2020

MedTech Access Leaders Forum (Winter)

Berlin, Germany - December 3-5, 2019
Presentation

Local Market Access in Germany

Related topics:
Availability: FREE
  • Addressees & Purposes
  • Challenges in compiling the right data
  • Current solutions and suitable data sources
  • Outlook to the future: a new claims data treasure through the digital care act?
Speaker

Michael Weisser
CEO
AIM Gmbh (Assessment-in-Medicine)

Presentation

Principles of MedTech market access: how to get technologies to patients faster

Related topics:
Availability: FREE

The principles of market access differ greatly from traditional 4 P  product price place promotion Marketing. The winning combination of clear demonstration of Patient, Provider Payer and Product benefits (Optimizing price but maximising the availability to patients who need the technology most) to HTA’s leads to faster adoption meaning patients receive great technologies sooner.

Speaker

Michael Branagan-Harris
CEO
Device Access UK

MedTech Commercial Leaders Forum

Brussels, Belgium - November 5-7, 2019
Presentation

Aligning commercially-focused teams to best practices in Value-Based Healthcare

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE

Value Based Healthcare requires a new way of thinking.  It requires fluently navigating clinical outcomes and economic costing.  This presentation will cover WHY VBHC is necessary, HOW Value based procurement enables VBHC, WHO needs to be involved in the collaborative dialogue, and WHAT the role of VBAPs are in overcoming clinical and economic uncertainty to drive medtech adoption.

Speaker

Ernesto M. Nogueira
CEO and Founder
ValueConnected

Presentation

Get the backing from the C-Suite: How to demonstrate ROI on your digital investments

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Understand how to turn the C-Suite into digital advocates 
  • Experience how the first movers in medtech have proven digital technology ROI
  • See how you can use your digital investments to enable better customer experiences for payers and HCPs
  • Explore how digital technology supports a key account strategy
  • Learn how to get it right: start small and scale fast 
Speaker

Nicolai Nygaard Worsøe
Client Director
Agnitio

MedAffairs Leaders Forum Europe

Zurich, Switzerland - November 5-7, 2019
Presentation

Biopharmaceutical Acceleration Model for product development and commercialization

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Meeting the needs of health system stakeholders demanding both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Case study: The benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker

Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK

Presentation

Leveraging online discussion platforms for optimal KOL & Physician engagement

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global KOL engagement 
  • Which solutions can enable Pharma & MedTech to better engage & generate valuable insights from KOLs & External Experts 
  • Improving KOL engagement outcomes while maintaining regulatory compliance
Speakers

Pauline De Mari
Vaccines Innovative Medical Engagement Lead
Sanofi

Andy Bowman
Managing Director
Within3

MedAffairs Leaders Forum USA

Boston - August 13-15, 2019
Presentation

Leveraging online discussion platforms for optimal insight generation & stakeholder engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement & insight retention
  • Learn about innovative communication solutions that leading organizations utilize to overcome these challenges and drive value-added insight development.
  • Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance
Speaker

Amy Pinelli
Regional Vice President, Business Partnerships
Within3

 

Presentation

Strategic stakeholder and account planning in the era of precision medicine

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE

As the life sciences industry shifts its understanding of customers to help meet organizational goals, account management can help power strategic partnerships in an increasingly complex healthcare landscape. The session audience will learn: 

  • Key developmental stages of a multi-dimensional account management model, the specific value drivers in each stage, and how to effectively leverage current and emerging data
  • How to build a strategic key account management (KAM) program that enables effective planning, visualization, and execution across accounts and teams
  • How to leverage data to drive collaboration among stakeholders. 
Speaker

Robert Groebel
Vice President - Global Medical/KAM Strategy
Veeva Systems

Nordic Evidence Leaders Forum

Stockholm, Sweden - May 14-15, 2019
Presentation

One region – one cohort: pooling Nordic data to achieve market access

Related topics: Pharmaceutical/Biotech, Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker

Thomas Fast
Project Manager & RWE Expert
Institute of Applied Economics & Health Research (ApHER)

MedTech Commercial Leaders Forum

Zurich, Switzerland - March 5-7, 2019
Presentation

Product Claim Management – An integral approach to systematically build clinical and economical product value.

Related topics: MedTech, Commercial, Regulations & Ethics
Availability: FREE
  • Beyond Marketing: Getting to the right product claims and getting the product claims right.
  • Beyond MDR: How to turn novel regulatory requirements into differentiating opportunities?
  • Beyond Product Launch: Clinical vs. economic claims? The right choices for effective Market Access. 
Speaker

Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands

Presentation

The Future of Learning and Enablement in Med Device: Continuous, Adaptive, Personalised

Related topics: MedTech, Commercial, Digital & Technology, Capabilities & Effectiveness
Availability: FREE

Industry consolidation, competition and product innovation are driving the medical device industry to constantly evolve if they are to keep up with market and patient needs.  This poses a great challenge, but also a great opportunity, to learning and enablement leaders who strive to successfully support sales, medical affairs and distribution partners to develop strong customer relationships and deliver the best technology solutions for the end patient or consumer. In this talk, you will learn:

  • How learning leaders are driving behaviour change that improves job performance
  • New ways to scale and measure the impact of enablement initiatives on commercial goals
  • Case studies of how medical device providers and other leading enterprises are achieving commercial agility
  • How to apply best practice microlearning to commercial, medical affairs and channel enablement
Speaker

Michael Connolly
Enterprise Account Director, EMEA
Qstream, UK

MedAffairs Leaders Forum

London, UK - February 26-28, 2019
Presentation

Bringing meaningful metrics to the new medical affairs model

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speakers

Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK

Charlotte Moseley
Global Head
Complete HealthVizion, UK

Presentation

Building Effective Medical Teams: Internal Vs External Approaches

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker

Gavin Kenny
Account Director
OPEN Health Medical Communications, UK

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 23-25, 2019
Presentation

Measuring the return from pharmaceutical innovation 2018

Related topics: Discovery & R&D Innovation, Digital & Technology
Availability: FREE

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.

Speaker

Mark Steedman
Research Manager
Deloitte UK Centre for Health Solutions

Presentation

Extreme-Scale Cloud-Based Infrastructure needed for global genomic data

Related topics: IT & Big Data
Availability: FREE
  • Cloud genomic data sets are approaching a total of 250 Petabytes representing an unprecedented resource for research and clinical applications
  • Extreme-scale cloud-based compute and tools are required to federate and utilize the emerging global resource, conforming to localized compliance requirements
  • A rapid evolution in data resource architecture and applicable tools is required, with an important role to be played by Artificial Intelligence
Speaker

Richard Daly
CEO
DNAnexus, Inc., USA

PHARMACCESS Leaders Forum

Berlin, Germany - December 4-5, 2018
Presentation

Bridging the gap: Translating expedited regulatory approval into optimal reimbursement

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Regulations & Ethics
Availability: FREE
Regulatory approval has traditionally been the main hurdle for developers trying to bring needed new drugs to patients. However, today, expedited regulatory pathways enable drugs for severe diseases to receive approval with less data whilst payers, in the face of budgetary pressures, are demanding more data. Thus, the gap has widened between what evidence regulators require and what payers desire.
 
Strategies to bridge this gap and translate regulatory approval into optimal reimbursement are becoming increasingly key to ensure the commercial success of innovative new products, which will be the focus of this presentation and will include:
- Making RCTs more payer relevant.
- Real world evidence utilization.
- Innovative pricing models.
- Early scientific advice.
Speakers

Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting

Richard Macaulay
Principal Consultant
Parexel

Presentation

Market access & go-to-market strategy for transformative therapies: Changing our mindset

Related topics: Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
  • The key go-to-market opportunities and challenges for autologous gene and cell therapies - from the regulatory (‘benefit/risk’), market access (funding and pricing) and commercialisation (treatment delivery) perspectives
  • The value of integrated, cross-functional decision-making, strategies and tactics to overcome go-to-market hurdles for autologous gene and cell therapies
  • The implications for Pharma around organisational structure, organisational processes and capabilities
Speaker

Akshay Kumar
Principal Consultant
Huron Consulting Group, UK

MedTech Access Leaders Forum

Berlin, Germany - December 3-5, 2018
Presentation

Enabling value selling for Surgical & Implantable Devices

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Triggering incremental funding for medical innovations

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Are traditional reimbursement systems adequate for innovation?
  • Rewarding value, not only cost or evidence
  • Innovative Payment Mechanisms in Europe
  • Implications to Market Access Strategy
Speaker

Ben Modley
Director of European Operations
ValueConnected

MedAffairs Leaders Forum Europe (Autumn)

Zürich, Switzerland - October 23-25, 2018
Presentation

“Value communication during pathway disruption” : The opportunity and challenge of disruptive medicine including CAR-T & Gene Therapy

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Defining pathway disruption
  • Challenges of value measurement
  • Market Access and Real World Evidence solutions to overcome challenges
Speaker

Amanda Pulfer
Managing Director
PH Associates

Presentation

Real World Evidence Opportunities in Medical Affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Areas of opportunity
  • Main hurdles
  • Elegant method to answer new questions with existing data
  • Methodology – bias and confounding
  • Opportunity for strategic partnership
  • Value for money
Speaker

Torkild Stenbock
General Manager
LINK Medical Research, Norway

MedTech Commercial Leaders Forum

London, UK - October 16-18, 2018
Presentation

Systematic Value Generation and Claim Prioritization based on Economic Impact

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Discover the relevant claim space for your target customer
  • Assess value and regulatory implications for aspired economic claims
  • Building a claim portfolio on differentiating impact before and after product launch
Speakers

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands

Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands

Presentation

The best buyer experience wins - How to use digital to leave a mark with the empowered buyer?

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Empowered buyer teams force Marketing & Sales to step up their game.
  • Marketing can support sales teams to become more solution-centric.
  • Sales teams can go beyond the expected and impact the modern-day buyer.
  • Ceterix, bioMérieux and ARGEN use sales enablement technology to step change Marketing and Sales alignment and grow sales productivity.
Speaker

Ellen Atkinson
Account Executive
Showpad

MedAffairs Leaders Forum USA

Boston, Massachusetts - July 31 - August 2, 2018
Presentation

Data and strategic perspective

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Anthony Page
CEO
Voxx Analytics

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape

Market Access in Latin America Leaders Forum

Brazil - June 13-14, 2018
Presentation

The economic impact of value on different payment models

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Overview of main payment mechanisms
  • Basics of hospital financing
  • Activity-based payments: DRG
  • Value-based payments
  • Shift to value: is it happening now?
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Value-Based Reimbursement: including a new procedure in the Brazilian Public Healthcare System (SUS)

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Quantification of the unmet need for SUS.
  • Development of cost-effectiveness and budget impact analyses.
  • Potential scenarios for SUS with inclusion of technology.
  • Project results and next steps.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

AI & BLOCKCHAIN Applications in Pharma R&D

Switzerland - May 30-31, 2018

PharmAccess Leaders Forum Spring

London, UK - April 17-18, 2018
Presentation

Changing Trends in Real World Evidence

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Payer expectations.
  • The regulatory landscape.
  • Access to data.
  • The Increasing voice of the patient.
  • What is in store for sponsor-CRO partnerships?
Speaker

Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK

Presentation

Early Access Programs – as a valuable component of market access and launch strategy

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Clinical
Availability: FREE
  • Understand how these programs have been used extensively by pharma companies to address unmet medical need, but have broader market access benefits including another source of real world data.  This session will help people understand the basics about EAPs, the current landscape and industry trends around EAPs, and the types of data that various companies are capturing.  A case study will be provided.
Speaker

Kieron Lewis
Global Business Development Director
Clinigen, UK

MedAffairs Leaders Forum (Spring)

London, UK - February 27 - March 1, 2018
Presentation

Leading MSLs to the best of their potential

Related topics: Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
  • Internal training
  • Engagement tool
  • Keeping the conversation going
Speakers

Annie Rankin
Client Partnerships Lead
Succinct Medical Communications

Gavin Kenny
Account Director
Succinct Medical Communications

Presentation

The power of consistent communication with HCPs and patients

Related topics: Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care
Availability: FREE
  • Keeping consistency in communications with both HCPs and patients to maximise high quality patient-HCP conversations
Speakers

Katie Corbin
Managing Director
Succinct Medical Communications

Richard Jones
Patient Services Director
The Earthworks (an OPEN Health Company)

Nordic Market Access Leaders Forum

Stockholm, Sweden - April 18-19, 2018
Presentation

Real world evidence: Opportunities and challenges with registry data

Related topics: Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE

- Real world data solutions in the post-marketing world: the multiple sclerosis experience

- Introduction to the MSBase international registry

- Methods for separating drug signals from bias in observational data

- Pharma / disease registry collaborations in comparative effectiveness analyses

- Big data: Big MS and beyond

Speaker

Tim Spelman
Senior Scientist
Synergus

MedTech Commercial Leaders Forum Europe

Zürich, Switzerland - February 20-21, 2018
Presentation

From NPS to an actionable customer centric listening program: A global approach

Related topics: MedTech, Commercial
Availability: FREE
  • Moving beyond NPS
  • Engaging a global team to get local customer insight
  • Maintaining the focus on the customer
  • Driving the global process forward.
  • It’s not just the numbers: Tell the story of the customer
Speakers

Shane West
VP Client Relations
Cetas Healthcare Insights, Norway

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, India

Presentation

Opportunities for digital technologies and services to drive value and access for Medtech

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • What does the new world of medtech and digital health look like?
  • How can digital technologies and services enhance the value of devices in a meaningful way to payers?
  • How will these innovative solutions be regulated and reimbursed?
Speaker

Anne Smart
Managing Director
ClearView Healthcare Partners, USA

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 23-24, 2018
Presentation

Challenges and opportunities for successful Real World Evidence strategy

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Nourdine Bouzekri
Principal Industry Consultant
SAS, France

Presentation

Putting the patient/citizen into the driving seat

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
  • The key elements to leverage the potential of electronic health care data: Where is the trust?
  • Regulations which might support it: GDPR and other regulations
  • Who are the partners/stakeholders and their major responsibilities?
  • Democratization of the analytics and data: Patients view and the citizen handle it?
  • Ethical consideration about not being in a position using the data: Another view or how interests might need a balance and who might be in charge?
Speaker

Peter Grolimund
Sr. Life Science Industry Consultant
ThinkBig Analytics (a Teradata company)

MedTech Access Leaders Forum

Berlin, Germany - December 5-7, 2017
Presentation

Enabling economic selling

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
Value Connected, Netherlands

Presentation

Real World Evidence the key to smart medical device market access

Related topics: MedTech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • It is all about the quality of the data.
  • RWE to understand target indication and plausibility of clinical trial success.
  • Single arm / registry to comparative effectiveness data.
Speaker

Mattias Kyhlstedt
CEO
Synergus AB, Denmark

MedTech Commercial Leaders Forum USA

Princeton - New Jersey - November 6-8, 2017
Presentation

Preparing commercial teams to demonstrate value, not features

Related topics: MedTech, USA, Commercial
Availability: FREE
  • More professional purchasers and decision makers need a different approach
  • Why price is not the priority for providers (even though it seems so)
  • Developing the value message: Quantifying benefits
  • Roadmap to preparing commercial teams to use value to justify price
  • Best practices from real case studies
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Embedding market access into the mergers & acquisitions process

Related topics: MedTech, USA, Market Access & HEOR
Availability: FREE
  • Market access supporting key value processes
  • The mergers & acquisitions process
  • Key issues examined during due diligence
  • Anonymised case studies
Speaker

Rob Wenthold
Vice President
Boston Healthcare Associates

PharmaValue Stakeholder Forum

Berlin, Germany - 10 October, 2017

MedAffairs Leaders Forum (Autumn)

Berlin, Germany - October 10-13, 2017
Presentation

Medical affairs information strategies for medical devices and how to take advantage of new requirements

Related topics: MedTech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker

William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group

Presentation

A pinch of strategy: Perfecting the recipe for success in medical affairs communications

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • The revolution in our kitchen: The changing landscape of medical Affairs.
  • Introducing new ingredients: A new blend of responsibility for medical affairs leaders.
  • Prepare, mix, bake: Using the right approach to create an effective and affective medical affairs plan.
  • Serving suggestions: How powerful communications can change patients’ lives.
Speakers

Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK

Rhiannon Meaden
Head of Commercial Development
Complete HealthVizion, UK

PharmAccess Leaders Forum (Autumn)

Berlin, Germany - October 10-12, 2017
Presentation

Future market access excellence: Enabling a dynamic organisation

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
  • New organisational capability needs to address major market changes.
  • Optimising global strategy and local agility: Updated planning and governance structures.
  • Cross-functional leadership and aligned KPIs.
  • Digital tools to drive efficiency, effectiveness and feedback.
Speaker

Chris Easley
Head of Market Access Solutions
Pope Woodhead and Associates Ltd.

Presentation

What’s it worth to you? Assessing value of product attributes through decision-analytic modelling

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • How a product’s characteristics or attributes contribute to both individual willingness to pay and “value” from different perspectives (e.g., stakeholder, society).
  • The various methodologies through which attribute value can be assessed.
  • A real-world case study of how decision-analytic modelling helped a leading medical device company establish the value of a unique product attribute, and by so doing justify higher tender pricing in a key EU market.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

Medical Affairs Leaders Forum USA

Princeton, New Jersey, USA - July 25-27, 2017
Presentation

The role of MSLs in the development of pre-market communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Commercial, Global (non-specific), Medical Science Liaison, Life Sciences (not-specific)
Availability: FREE
  • Medical Affairs and MSL synchronicity: Linking efforts to ensure a positive outcome.
  • MSLs and KOLs: The data sweet spot: Finding balance within the current regulatory environment.
  • The role of MSLs in audience engagement: Strategic & tactical approaches to engagement.
  • MSL-directed educational communications: An appropriate path forward.
  • Measuring the impact of MSL-driven activities: Applying metrics to establish impact.
Speaker

Tim Day
Principal 
Innovative Strategic Communications

Presentation

Achieving world-class execution in medical affairs

Related topics: Pharmaceutical/Biotech, USA, Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE

With the rise of medical affairs as healthcare’s core scientific partner, industry leaders are reimagining their organizations to achieve a world-class standard–and deliver greater value. Learn how to align engagement strategies to healthcare stakeholders’ scientific goals and interests, based on actionable insights.

Speakers

Robert Groebel 
Vice President - Global Medical Strategy 
Veeva

Brian Harper
Senior Director, Medical Content Strategy
Veeva 

PharmAccess Leaders Forum (Spring)

Milan, Italy - May 3-5, 2017
Presentation

The Patient as the Payer: What drives patients’ willingness-to-pay?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Patient-Centricity & Care
Availability: FREE
Speaker

Adrien Gras
Vice President Europe, Market Access
GFK, UK

Presentation

Bio-similar, but different: Establishing (or defending) value through Multi-Criteria Decision Analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing Upstarts (marketers of biosimilars) and Defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

MedTech Commercial Leaders Forum (Europe)

Zurich, Switzerland - February 20-22, 2017
Presentation

Success case study: Driving bottom-line surge using salesforce analytics, salesforce sizing and deployment issues

Related topics: MedTech, Commercial, Global (non-specific)
Availability: FREE
  •  Promotion response modelling for ROI on sales calls to derive optimal size.
  •  Territory alignment based on Potential Index and Workload Index.
  •  Incentive design for salesforce based on fairness, motivation and financial risk.
Speaker

Sumit Mehta
Managing Director
Cetas Healthcare Insights

Presentation

Improving commercial effectiveness at scale: A Boston Scientific case study

Related topics: MedTech, Commercial, Global (non-specific)
Availability: FREE
  •  Identifying commercial learning challenges.
  •  Shifting middle performers.
  •  Implementing solutions to support continuous commercial learning at scale.
  •  The path to continued commercial effectiveness.
Speakers

Jay Bratcher 
Training Manager, New Cardio, Europe 
Boston Scientific, UK

Michael Quann
Director Strategic Account
Qstream, Ireland

Medical Affairs Leaders Forum (Spring)

Zürich, Switzerland - February 28 - March 2, 2017
Presentation

A matter of perspective: Evolving the MSL role for the long-term development of next-generation KOLs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Medical Science Liaison
Availability: FREE
  • What is the role of an MSL today in developing strategic relationships with KOLs.
  • Learn what a typical ‘day in the life’ of an MSL is like.
  • Is the role of an MSL here to stay for the long term?
Speaker

Sital Kotecha
Medical Strategy Director, Europe
Veeva Systems, UK

Presentation

Pre-Market Communications: Reaching your audience in today’s complex environment

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • The importance and benefits of an effective pre-market communication plan.
  • The when, where and how of the various elements who need to be engaged.
  • Development and implementation of the plan: Where the magic happens and results are driven!
  • The essential elements to any pre-market communication plan.
  • The need for achieving balance between the speed, timing and volume of pre-market communications.
Speaker

Tim Day
CEO & Principal
Innovative Strategic Communications, USA

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 24-26, 2017
Presentation

Opportunities and challenges using unsolicited, self-reported, health outcomes data from open web-based media sources

Related topics: Pharmaceutical/Biotech, IT & Big Data, Global (non-specific), Digital & Technology
Availability: FREE
  • An ever-increasing number of individuals routinely contribute and consume solicited and unsolicited information about a variety of health-related issues using a wide range of internet and social media channels.
  • Personal web-based reports on health status, symptoms, treatments and associated interventions may provide a rich source of data to support discovery, clinical development and post marketing analytics.
  • A key challenge in the applicability and utility of these data is related to the veracity, accuracy and reliability of information collected from web-based media sources.
Speaker

Mark Wolff
Advisory Industry Consultant, Chief Health Analytics Strategist
Health & Life Sciences Global Practice, SAS Institute, USA

Presentation

Leading patient engagements: From patient data analytics to mHealth interventions

Related topics: Pharmaceutical/Biotech, IT & Big Data, Global (non-specific), Patient-Centricity & Care, Digital & Technology
Availability: FREE
Speaker

Alexander Frenzel
Senior Manager, Business Development T&A, QuintilesIMS, Germany

MedTech Access Leaders Forum

Berlin, Germany - December 6-8, 2016
Presentation

Market access challenges and opportunities for clinical applications of Next Generation Sequencing (NGS)

Related topics: MedTech, Diagnostics, Europe, Market Access & HEOR
Availability: FREE
  • Review of benefits of NGS and challenges associated with securing payment for multiplex testing technologies.
  • Overview of EU5 payment systems for diagnostics.
  • Case studies: Payment for NGS oncology applications in Germany and France.
  • Case studies: Reimbursement initiatives for non-invasive, prenatal testing.
  • Best practices/insights for innovators.
Speaker

Charles Mathews
Vice President
Boston Healthcare, USA

Presentation

Translating hospitals’ needs into actual value stories

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
  • Identifying decision-makers’ needs.
  • Assessing the relevant data to support claims.
  • Building a concrete value story.
  • Next steps: Teams, not tools, demonstrate value.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Medical Affairs Leaders Forum (Autumn)

London, UK - October 18-20, 2016
Presentation

Live events in the digital age: Case Study of a catalyst for building integrated and sustained engagement with healthcare professionals

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
  • The problem: High investment with limited reach and high output that is short-lived.
  • The objective: Capitalising on events to extend the value through sustained targeted engagement.
  • The strategy: An end-to-end programme designed to be multicontent, multi-event & multi-channel.
  • The evidence: Research and metrics that supports this approach and better outcomes.
Speaker

Tiberio Catania
Commercial Director
EPG Health Media, UK

Presentation

Breaking the “fail-cycle” of KOL CRM Solutions

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE

A plethora of studies suggest that an astonishing 50 – 75% of all CRM implementations fail in some form. So we started our KOL CRM development programme with the assumption “why should ours be any different?” Our two-year case study highlights the many challenges we (vendor & our clients) encountered in the medical affairs context, our many failings, and the innovations we built to overcome them. We’ll also present a simple framework for Medical Affairs to help maximise the success of CRM implementations to boost external expert management.

Speaker

Sanjay Singhvi
Director, System Analytic, UK

PharmAccess Leaders Forum (Autumn)

Berlin, Germany - September 27-29, 2016
Presentation

Biosimilar, but different: Establishing (or defending) value through multi-criteria decision analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing upstarts (marketers of biosimilars) and defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
MAPE, Vice President
Truven Health Analytics, USA

Presentation

Cell & gene therapies: A global perspective of HTA, funding & reimbursement challenges

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Overview of cell & gene therapies.
  • Health technology assessment & cost effectiveness challenges.
  • Who pays? Healthcare system determinants of funding / reimbursement.
  • Affordability: Pricing and budget impact challenges.
  • Lessons learned: Early case studies.
Speaker

Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.

Market Access in Latin America Leaders Forum

São Paulo, Brazil - July 12-14, 2016
Presentation

Is your market access organization ready for the evolving access challenges in Latin America?: A primer on organizational development to reflect marketplace changes.

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Latin America
Availability: FREE
Speakers

Miguel Martin de Bustamante
Associate, CBPartners

Sandeep Duttagupta
Vice President, CBPartners

Medical Affairs Leaders Forum (Asia)

Singapore - July 20-21, 2016
Presentation

Navigating post-marketing requirements worldwide: What to anticipate as you move towards submission

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  • Review of post-marketing requirements in the USA, Europe, and South Korea.
  • How to interpret the demand of the authorities,
  • Proactive planning to drive design.
  • Real-world case studies from the USA, Europe and South Korea.
Speaker

Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services,
PRA Health Sciences

Presentation

Practical strategies for implementing RWE studies in Asia Pacific

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  • Differences between real-world evidence studies and randomized controlled trials.
  • Asia Pacific country specific examples of real-world evidence studies.
  • Local regulations on study approval and execution.
  • KOL value and working with investigators in APAC.
Speakers

William Maier
Chief Scientific Officer, Mapi Group, UK

Isabelle Grau
Director, Real World Evidence APAC, Mapi Group, Australia

Nordic Market Access Leaders Forum

Stockholm, Sweden - April 19-20, 2016

PharmAccess Leaders Forum (Spring)

London, UK - April 26-28, 2016
Presentation

Global review of innovative pricing arrangements: Shifting dynamics and new considerations

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • Payer perception/considerations of innovative pricing in the context of health budget pressures.
  • Analytics overview of geographies and therapeutic areas where key changes are occurring.
  • Key strategic lessons over how these agreements are being designed.
Speaker

Gustav Ando
Vice President of Life Sciences
IHS

Presentation

Understand the real drivers of HTA decision-making in oncology: What clinical and economic factors influence positive vs negative recommendations?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Oncology
Availability: FREE
  • How do payers evaluate products in an increasingly crowded marketplace.
  • How successful are companies in getting new products approved?
  • Comparing major payers: Where are similarities and where are the difference in their evaluations?
  • Do companion diagnostics make a difference in the approval success rate?
Speaker

Anke van Engen
Principal, Advisory Services, Quintiles, Netherlands

Medical Affairs Leaders Forum (Spring)

Berlin, Germany - February 22-23, 2016
Presentation

Leveraging support programmes to enhance medical communications

Related topics: Pharmaceutical/Biotech, Europe, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • How pharma can utilise digital programmes to support publication strategy.
  • Using materials and real world evidence to reach new KOL audiences.
Speaker

Ian Smyth
Director
MEDNET Consult

Presentation

The changing face of KOL partnerships

Related topics: Pharmaceutical/Biotech, Europe, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Compliance and transparency regulations are causing many pharmaceutical companies to re-evaluate how they pay and partner with external experts.
  • How do we define a KOL and what are models for effective KOL engagement in the changing environment?
Speaker

Rob Barker
CEO, Succinct Medical Communications, UK

Medical Device Commercial Leaders Forum (Europe)

Brussels, Belgium - February 16-18, 2016
Presentation

Six key buyer trends reshaping MedTech selling & pricing

Related topics: MedTech, Europe, Market Access & HEOR, Commercial
Availability: FREE

The MedTech industry is at an inflection point. Healthcare providers at every level are professionalising their procurement and creating tectonic shifts in their demands on your pricing, sales, and tendering and contracting operations. While the industry appears to be aware of these shifts and what the impacts will be, many MedTech companies are struggling to identify and prioritise the changes they need to make to stay ahead of these trends without sacrificing revenue or growth.

Speaker

Peter Zimmermann
Director Customer Success Europe
Model N, Switzerland

Presentation

Developing a commercial model based on value

Related topics: MedTech, Europe, Market Access & HEOR, Commercial
Availability: FREE
  • Early stage or product launch: When is the right moment to focus on value?
  • Identifying the key value propositions to drive the market.
  • Building the relevant economic data to support value claims.
  • Case example: From feature-centric to value-based model
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

R&D Big Data Leaders Forum

London, UK - January 19-21, 2016
Presentation

Breaking the classical barriers to collaboration and scientific discovery: Distance and data size

Related topics: Pharmaceutical/Biotech, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE

Life sciences organisations need to dramatically reduce analytics time and speed up clinical interventions, but most still rely on shipping physical disks due to inherent problems with existing networks and transfer protocol inefficiencies. Spending days to transport data is not a viable option, this session will explore technology infrastructure for file transfer that will catalyse the transition from 1GbE to 10GbE and beyond.

  • Enabling geographically distributed collaborative teams to exchange huge data sets at maximum speed, regardless of distance and network conditions.
  • Utilising proven, secure and reliable transfer technology, widely adopted for business-critical data movement.
  • Transferring large data sets, including next-generation genomic sequencing sets, amounting to hundreds of gigabytes.
Speaker

Per Hansen
Regional Manager Sales Engineering EMEA, Aspera (an IBM Company),UK

Presentation

From Big Data to precision medicine: Trends, challenges & opportunities

Related topics: Pharmaceutical/Biotech, Diagnostics, Clinical, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
Speaker

Thomas Wilckens
Chief Executive Officer, CSO & Founder, InnVentis, Germany

MedTech Access Leaders Forum

December 8-10, 2015
Presentation

Leveraging Real-World Evidence (RWE) in medical device reimbursement

Related topics: MedTech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • What do we mean by RWE?
  • Usefulness and limitations of RWE in supporting medical device reimbursement.
  • Case studies of the successful use of RWE in device reimbursement.
  • Summary.
Speaker

Stuart Mealing
Principal Economist, European Practice Lead
ICON, UK

Presentation

Building economic evidence towards compelling value propositions

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
  • Early stage or commercialisation: When is the right moment to focus on economic evidence?
  • Identifying what decision-makers are looking for.
  • Less is more: Identifying the relevant data to support value claims.
  • Case example: From evidence to compelling value proposition.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Medical Affairs Leaders Forum (Autumn)

October 21-22, 2015
Presentation

NICE’s Medical Technologies Evaluation Programme: A global view of a national HTA

Related topics: MedTech, Europe, UK, Market Access & HEOR
Availability: FREE
  • How applicable is MTEP outside of England?
  • How does MTEP compare to other MedTech HTA?
  • What benefit is there to submitting to MTEP?
Speaker

Joanna Entwistle
Principal Consultant, GFK Market Access, UK

Presentation

Enhancing your medical affairs communications practices

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE

How do we avoid the greatest threat to carefully crafted medical strategy – the inevitable boiling down of delicately nuanced arguments into bullet points, charts and tables? To the outside observer it appears to be largely generic and is hardly reassuring to senior stakeholders who must bless it, or clear to those who must ultimately implement it. This presentation will discuss how to create and communicate your medical strategy in a way that informs and inspires the reader.

Speaker

Robert Barker
CEO, Succinct Medical Communications, UK

PharmAccess Leaders Forum (Autumn)

October 13-15, 2015
Presentation

HTA, funding & reimbursement of cell & gene therapies: A global perspective

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Health technology assessment challenges in assessing clinical and cost effectiveness of cell / gene therapies.
  • Who pays? Healthcare system determinants of funding/reimbursement paradigm.
  • Affordability: Pricing and budget impact challenges
Speaker

W. Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.

Presentation

Central and Eastern Europe: Diversity to tame, market access potential to unveil

Related topics: Pharmaceutical/Biotech, MedTech, Europe, Market Access & HEOR, Central Eastern Europe
Availability: FREE
  • Regional diversities in approaches to public funding decision making.
  • Comparative measures to enable informed allocation of company strategic efforts.
  • Analysis of public funding decision making practice as a tool to identify risks and opportunities and to provide unbeatable arguments to CEE decision makers
Speaker

Norbert Wilk
Director, Market Access Consulting
Arcana Institute, Poland

Medical Affairs Leaders Forum Asia

Singapore - August 4-5, 2015
Presentation

Mapping real-world centers: Can it be done?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
Speaker

Karen Wai
Vice President, Regional Managing Director Real-World & Late Phase Research, Asia Pacific
Quintiles, Singapore

Presentation

RWE in Asia: Has its time finally come?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  •  Current state of RWE in Asia markets.
  •  Key trends and how it is evolving.
  •  What this means for healthcare companies.
Speaker

Sheryl Jacobson
Asia Head of Life Science and Healthcare Consulting 
Deloitte

Clinical Research in Turkey Middle East and North Africa Leaders Forum

Dubai - United Arab Emirates - June 8-9, 2015
Presentation

The importance of achieving recruitment targets in MENA

Related topics: Pharmaceutical/Biotech, Clinical, Middle East
Availability: FREE
  •  Why is recruitment important?
  •  Issues seen in studies (generally not just MENA).
  •  What are the possible reasons for this?
  •  Are there differences between MENA and ROW in patient recruitment numbers and retention rates?
  •  How could we actively prevent these issues?
  •  Case studies (both good and bad) & lessons learned.
Speaker

Myriam El-Khazen
General Manager 
INC Research, Greece

Oncology Clinical Leaders Forum

Brussels, Belgium - May 11-12, 2015
Presentation

Multilateral recruitment approach for early phase oncology trials: Weights and balances

Related topics: Pharmaceutical/Biotech, Clinical, Global (non-specific), Oncology
Availability: FREE
  • Key challenges in early phase oncology recruitment.
  • Therapeutic, supportive and other compounds from trial management perspective.
  • Pros and cons of early phase trials for the investigator and for the cancer patient.
  • Role and potential of professional CPU (Clinical Pharmacology Unit) within indication.
  • Satellite Centre Concept for proper recruitment and controlled quality.
Speaker

Istvan Udvaros 
Medical Director, Project Director of Oncology
SGS LSS Clinical Research, Belgium

Presentation

Mass balance/ADME studies in oncology patients: Successful answers to the challenge in Central and Eastern Europe

Related topics: Pharmaceutical/Biotech, Europe, Clinical, Central Eastern Europe, Oncology
Availability: FREE
  • Patient pharmacology services: Concept and operational set up.
  • ADME concepts, incl. micro-dose and tracer-dose.
  • Underlying dossier requirements incl. preclinical safety package.
  • General design considerations incl. radiodose and radioburden calculation.
  • Devil is in the details: Operational challenges.
  • Selection of geographic region and patient population.
  • Ethical aspects.
Speaker

Agnes Rethy 
Associate Director of Clinical Operations
EDS Patient Pharmacology Services
PRA Health Services

Market Access & Commercial Excellence Forum Asia

Singapore - August 5-6, 2015
Presentation

Building the market to gain market access in Asia-Pacific countries: From a transactional player to a strategic partner

Related topics: MedTech, Market Access & HEOR, Asia Pacific
Availability: FREE
  • What value does your technology bring to address the needs of the country’s health system?
  • How can you develop the market to create a receptive and favorable environment for your technology?
  • Case study: Established vs. emerging markets.
Speaker

Anne Smart
Director
Navigant, USA

Medical Affairs Leaders Forum Spring

Berlin, Germany - February 26-27, 2015
Presentation

Effectively incorporate communications in product commercialisation

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Developing and implementing a scientific strategy to effectively disseminate evidence and show value and engaging with diverse stakeholders.
  • Understanding how, when, and to whom you communicate evidence.
  • Benefits and challenges of consistent communications.
Speaker

Gillian Boucher
Director, Medical Writing and Editorial
Quintiles

Presentation

What do we call KOLs if we can’t call them “KOLs”?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • The term “KOL”: Too toxic for everyday use, or still the best tool for the job?
  • Results from a survey of pharma and KOLs on the use of terminology alternatives.
  • Should pharma work towards using one universal replacement for the term “KOL”?
  • How does this change the way we engage with KOLs and stakeholders in medical affairs?
  • And what exactly do KOLs think of all this?
Speaker

Sanjay Singhvi  
​Director
System Analytic, UK

Medical Device Commercial Leaders Forum Europe

Brussels, Belgium - February 18-19, 2015
Presentation

Gamification and mobile reinforcement: How science from Harvard Medical School is driving a new approach to healthcare training

Related topics: MedTech, Commercial, Global (non-specific), Digital & Technology
Availability: FREE
  • Ground breaking technology from Harvard Medical School.
  • Used by life science sales teams and healthcare professionals.
  • Extend retention of complex processes and facts from weeks to years.
  • Mobile and social gaming methods to drive adoption and motivation.
  • Maximise return on investment in product training.
     
Speaker

Louella Morton
VP International Sales & General Manager
Qstream

Presentation

Accelerating sales with sales driven marketing

Related topics: MedTech, Commercial
Availability: FREE

In today’s digital age, marketers can use marketing automation and analytics technology enabling them to be hyper-relevant to the customer via online channels. But what happens when the customer schedules a call or meeting with your sales team? How do you know whether or not your content performs well during this offline phase of the customer journey? Learn how to grow your business by supporting your sales and indirect channels with sales driven marketing.

Speaker

Pieterjan Bouten
Chief Executive Officer
Showpad, Belgium

Medical Device Hospital Procurement and Payer Forum

Brussels Belgium - 17 February, 2015

Business Development Skills Tactical Training

.
Presentation

Workshop Overview - What you will learn

Related topics:
Availability: FREE
  • Target Audience
  • Why this course?
  • Why is sales a life skill?
  • Course Outcomes
  • What will you achieve?

 

Speakers

Geoff Cable                               
CEO & co-Founder                         
NextLevel Life Sciences

Luke Rogers
CEO & co-Founder
NextLevel Life Sciences

Register to view both free videos and browse premium content (and event documentation).

1938
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!